Rapamycin blocks induction of the thermogenic program in white adipose tissue

Diabetes

Volumn 65, Issue 4, 2016, Pages 927-941

  Tran, Cassie M ^a   Mukherjee, Sarmistha ^a   Ye, Lan ^b   Frederick, David W ^a   Kissig, Megan ^a   Davis, James G ^a   Lamming, Dudley W ^c   Seale, Patrick ^a   Baur, Joseph A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CYCLIC AMP DERIVATIVE; FATTY ACID; GLUCOSE; MESSENGER RNA; OXYGEN; RAPAMYCIN; UNCOUPLING PROTEIN 1; 1,3 DIOXOLANE DERIVATIVE; DISODIUM (R,R)-5-(2-((2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)-AMINO)PROPYL)-1,3-BENZODIOXOLE-2,3-DICARBOXYLATE;

ADIPOCYTE; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CELL MEMBRANE PERMEABILITY; COLD TOLERANCE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INSULIN RESPONSE; MALE; MITOCHONDRIAL BIOGENESIS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NONSHIVERING THERMOGENESIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; WHITE ADIPOCYTE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; THERMOGENESIS; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ANIMALS; DIOXOLES; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; SIROLIMUS; THERMOGENESIS;

EID: 84962141694     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0502     Document Type: Article

References (47)

1. Lamming DW, Ye L, Sabatini D.M., Baur JA. Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 2013; 123:980-989
2. Houde VP, Brûlé S, Festuccia WT, et al. Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluco-neogenesis and impairing lipid deposition in adipose tissue. Diabetes 2010; 59: 1338-1348
3. Aggarwal D, Fernandez ML, Soliman GA Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs. Metabolism 2006; 55:794-802
4. Morrisett JD, Abdel-Fattah G, Hoogeveen R., et al. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res 2002; 43:1170-1180
5. Brattström C., Wilczek HE, Tydén G, Böttiger Y, Säwe J, Groth CG. Hypertriglyceridemia in renal transplant recipients treated with sirolimus. Transplant Proc 1998; 30:3950-3951
6. Gyurus E, Kaposztas Z, Kahan BD Sirolimus therapy predisposes to newonset diabetes mellitus after renal transplantation: a long-term analysis of various treatment regimens. Transplant Proc 2011; 43:1583-1592
7. Lamming DW, Ye L, Katajisto P., et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335: 1638-1643
8. Sarbassov DD, Ali SM, Sengupta S, et al Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006; 22:159-168
9. Schreiber KH, Ortiz D, Academia E.C., Anies AC, Liao CY, Kennedy BK. Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins. Aging Cell 2015; 14:265-273
10. Blättler S.M., Cunningham JT, Verdeguer F, et al Yin Yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/IGF signaling. Cell Metab 2012; 15:505-517
11. Fang Y, Westbrook R, Hill C., et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab 2013; 17:456-462
12. Gesta S, Tseng YH, Kahn CR Developmental origin of fat: tracking obesity to its source. Cell 2007; 131:242-256
13. Seale P, Bjork B, Yang W., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008; 454:961-967
14. Wu J, Boström P, Sparks L.M., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150:366-376
15. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013; 19:1252-1263
16. Cohen P, Levy JD, Zhang Y, et al Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 2014; 156:304-316
17. Qiu Y, Nguyen KD, Odegaard J.I., et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157:1292-1308
18. Seale P, Conroe HM, Estall J, et al Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J Clin Invest 2011; 121: 96-105
19. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011; 14:575-585
20. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4:579-591
21. Guilherme A, Virbasius JV, Puri V, Czech MP Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377
22. Lavie CJ, Milani RV, Ventura HO Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53:1925-1932
23. Harrison DE, Strong R, Sharp Z.D., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392-395
24. Sengupta S, Peterson TR, Laplante M, Oh S., Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010; 468: 1100-1104
25. Eguchi J, Wang X, Yu S., et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab 2011; 13:249-259
26. Miller RA, Harrison DE, Astle C.M., et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 2014; 13:468-477
27. Roth Flach R.J., Matevossian A, Akie T.E., Negrin KA, Paul MT, Czech MP. β3-Adrenergic receptor stimulation induces E-selectin-mediated adipose tissue inflammation. J Biol Chem 2013; 288:2882-2892
28. Grujic D, Susulic VS, Harper M.E., et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 1997; 272:17686-17693
29. Vallerand AL, Jacobs I. Energy metabolism during cold exposure. Int J Sports Med 1992; 13(Suppl. 1):S191-S193
30. Vallerand ALLJ, Lupien J, Bukowiecki LJ Interactions of cold exposure and starvation on glucose tolerance and insulin response. Am J Physiol 1983; 245: E575-E581
31. de Jesus L.A., Carvalho SD, Ribeiro M.O., et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 2001; 108:1379-1385
32. Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol 2011; 214:242-253
33. Polak P, Cybulski N, Feige J.N., Auwerx J., Rüegg MA, Hall MN. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8:399-410
34. Liu M, Bai J, He S., et al. Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1. Cell Metab 2014; 19: 967-980
35. Xiang X, Lan H, Tang H., et al. Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch. Diabetes 2015; 64:519-528
36. Soliman GA, Acosta-Jaquez HA, Fingar DC. mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes. Lipids 2010; 45:1089-1100
37. Kumar A, Lawrence JC Jr, Jung DY, et al. Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 2010; 59:1397-1406
38. Degerman E, Belfrage P, Manganiello VC Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 1997; 272:6823-6826
39. Blancquaert S, Wang L, Paternot S., et al. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mito-genesis and activation of CDK4. Mol Endocrinol 2010; 24:1453-1468
40. Van de Velde S, Hogan MF, Montminy M. mTOR links incretin signaling to HIF induction in pancreatic beta cells. Proc Natl Acad Sci U S A 2011; 108:16876-16882
41. Xie J, Ponuwei GA, Moore C.E., Willars GB, Tee AR, Herbert TP. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Cell Signal 2011; 23: 1927-1935
42. Mullins GR, Wang L, Raje V., et al. Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes. Proc Natl Acad Sci U S A 2014; 111:17450-17455
43. Fisher FM, Kleiner S, Douris N., et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 2012; 26:271-281
44. Lee P, Linderman JD, Smith S, et al Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab 2014; 19:302-309
45. Rao RR, Long JZ, White J.P., et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014; 157:1279-1291
46. Ye L, Wu J, Cohen P., et al. Fat cells directly sense temperature to activate thermogenesis. Proc Natl Acad Sci U S A 2013; 110:12480-12485
47. Liu D, Bordicchia M, Zhang C., et al. Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. J Clin Invest. In press